Big Move For Avenue Therapeutics, Inc.
Thu, Dec 17, 2020 at 05:30 PM
Avenue Therapeutics, Inc. (ATXI:NASDAQ) rocketted at $5.45, a gain of 47.7%. On Wed 16 Dec 20, ATXI:NASDAQ hit a New 2-Week Intraday High of $3.75. The stock appeared on our News Catalysts scanner on Thu 17 Dec 20 at 07:58 AM in the 'INVESTOR UPDATE' category. From Wed 02 Dec 20, the stock recorded 60.00% Up Days and 45.45% Green Days
The share price of the company has been moving sideways in recent weeks.
About Avenue Therapeutics, Inc. (ATXI:NASDAQ)
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of an intravenous, or IV, formulation of tramadol HCl, or IV Tramadol, for the management of moderate to moderately severe postoperative pain.
Top 10 Gainers:
- SCPS (SCPS:NASDAQ), 473.65%
- YGMZ (YGMZ:NASDAQ), 336.41%
- WNW (WNW:NASDAQ), 88.17%
- Takung Art Co., Ltd. (TKAT:NYSEMKT), 71.43%
- Nxt-ID, Inc. (NXTD:NASDAQ), 54.22%
- Avenue Therapeutics, Inc. (ATXI:NASDAQ), 47.7%
- BQ (BQ:NYSE), 46.14%
- VVOS (VVOS:NASDAQ), 34.37%
- TuanChe Limited (TC:NASDAQ), 33.49%
- Naked Brand Group Limited (NAKD:NASDAQ), 29.31%